Literature DB >> 874070

Comparative evaluation of three different commercial blood culture media for recovery of anaerobic organisms.

J I Mangels, L H Lindberg, K L Vosti.   

Abstract

A comparison of three different commercial media was made to assess their recovery of anaerobic organisms from the blood stream. The three media used were the 50-ml brain heart infusion broth with added CO2 (Pfizer), the 50-ml Thiol broth with added CO2 (Difco), and the 50-ml prereduced, supplemented peptone broth in a Vacutainer tube with added CO2 (Becton-Dickinson). During a period of 17 consecutive months, 12,216 specimens of blood were processed with each broth. Aerobic or anaerobic bacteria were recovered from 913 specimens (7%). Seventy-four specimens (8%) of the total positive cultures contained anaerobic organisms. When potential contaminants were removed from the totals, 7% of the positive cultures contained anaerobic organisms and 7% of the patients with positive cultures had bacteremia with anaerobic bacteria. Of the three commercial blood culture media studied, the prereduced, supplemented peptone broth recovered more anaerobic organisms than did either the brain heart infusion or Thiol broths.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874070      PMCID: PMC274640          DOI: 10.1128/jcm.5.5.505-509.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Clinical laboratory evaluation of the fifty-milliliter vacutainer blood culture tube.

Authors:  B G Painter; H D Isenberg
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

2.  Comparison of three blood culture media for recovery of anaerobic bacteria.

Authors:  J A Washington; W J Martin
Journal:  Appl Microbiol       Date:  1973-01

3.  Evaluation of four blood culture systems using parallel culture methods.

Authors:  R Rosner
Journal:  Appl Microbiol       Date:  1974-08

4.  Anaerobic bacteremia.

Authors:  W R Wilson; W J Martin; C J Wilkowske; J A Washington
Journal:  Mayo Clin Proc       Date:  1972-09       Impact factor: 7.616

5.  Evaluation of two commercially available media for detection of bacteremia.

Authors:  J A Washington
Journal:  Appl Microbiol       Date:  1972-05

6.  Comparison of two commercially available media for detection of bacteremia.

Authors:  J A Washington
Journal:  Appl Microbiol       Date:  1971-10

7.  Bacteremia after genitourinary tract manipulation: bacteriological aspects and evaluation of various blood culture systems.

Authors:  N M Sullivan; V L Sutter; W T Carter; H R Attebery; S M Finegold
Journal:  Appl Microbiol       Date:  1972-06

8.  Detection of bacteremia with liquid media containing sodium polyanetholsulfonate.

Authors:  M Hall; E Warren; J A Washington
Journal:  Appl Microbiol       Date:  1974-01

9.  Rapid diagnosis of bacteremia.

Authors:  S M Finegold; M L White; I Ziment; W R Winn
Journal:  Appl Microbiol       Date:  1969-09

10.  Bacteremia after tooth extractions studied with the aid of prereduced anaerobically sterilized culture media.

Authors:  J J Crawford; J R Sconyers; J D Moriarty; R C King; J F West
Journal:  Appl Microbiol       Date:  1974-05
View more
  4 in total

Review 1.  Detection of bloodstream infections in children.

Authors:  J M Campos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

2.  Quantitative evaluation of three commercial blood culture media for growth of anaerobic organisms.

Authors:  J I Mangels; L H Lindberg; K L Vosti
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

3.  Evaluation of a routine anaerobic subculture of blood cultures for detection of anaerobic bacteremia.

Authors:  J W Paisley; J E Rosenblatt; M Hall; J A Washington
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

4.  Laboratory experience with radiometric detection of bacteremia with three culture media.

Authors:  K Wicher; D Koscinski
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.